Dendritic cells from HIV controllers have low susceptibility to HIV-1 infection in vitro but high capacity to capture HIV-1 particles

PLoS ONE

Volumn 11, Issue 8, 2016, Pages

  Hamimi, Chiraz ^a,h   David, Annie ^a   Versmisse, Pierre ^a   Eiss, Laurence ^a,b,c   Bruel, Timothée ^a,d,e   Zucman, David ^f   Appay, Victor ^g,h   Moris, Arnaud ^g,h,i   Ungeheuer, Marie Noëlle ^a   Lascoux Combe, Caroline ^j   Barré Sinoussi, Françoise ^a   Muller Trutwin, Michaela ^a   Boufassa, Faroudy ^k   Lambotte, Olivier ^d,e,h,l   Pancino, Gianfranco ^a   Sáez Cirión, Asier ^a  

^a INSTITUT PASTEUR   (France)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d UNIVERSITÉ PARIS SACLAY   (France)

^e INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

^f FOCH HOSPITAL   (France)

^g SORBONNE UNIVERSITÉ   (France)

^h INSERM   (France)

ⁱ Assistance publique Hôpitaux de Paris   (France)

^j SAINT LOUIS HOSPITAL   (France)

^k CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^l ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

C TYPE LECTIN RECEPTOR; CD16 ANTIGEN; CD209 ANTIGEN; CD32 ANTIGEN; CD4 ANTIGEN; CD64 ANTIGEN; CHEMOKINE RECEPTOR CCR5; LECTIN RECEPTOR; MISMATCH REPAIR PROTEIN; SYNDECAN 3; UNCLASSIFIED DRUG; LECTIN; VIRUS ANTIGEN;

ANTIRETROVIRAL TREATMENT; ANTIVIRAL THERAPY; ARTICLE; CD8+ T LYMPHOCYTE; CELL SURFACE; CELLULAR IMMUNITY; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS PRESENTATION; DENDRITIC CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS CONTROLLER; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IN VITRO STUDY; INFECTION RISK; INFECTION SENSITIVITY; MOLECULAR DYNAMICS; MONOCYTE DERIVED DENDRITIC CELL; NONHUMAN; PARTICLE CAPTURE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; TIME SERIES ANALYSIS; VIRAL PHENOMENA AND FUNCTIONS; VIRUS LOAD; VIRUS PARTICLE; CYTOLOGY; DISEASE PREDISPOSITION; GENE EXPRESSION REGULATION; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; VIROLOGY; VIRUS REPLICATION;

ANTIGENS, VIRAL; CD8-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; DISEASE SUSCEPTIBILITY; GENE EXPRESSION REGULATION; HIV INFECTIONS; HIV-1; HUMANS; LECTINS, C-TYPE; SYNDECAN-3; VIRUS REPLICATION;

EID: 84983354564     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0160251     Document Type: Article

References (42)

1. Saez-Cirion A, Pancino G. HIV controllers: a genetically determined or inducible phenotype? Immunol Rev. 2013; 254(1):281-94. Epub 2013/06/19. doi: 10.1111/imr.12076 PMID: 23772626.
2. Walker BD, Yu XG. Unravelling the mechanisms of durable control of HIV-1. Nat Rev Immunol. 2013; 13(7):487-98. Epub 2013/06/26. doi: 10.1038/nri3478 PMID: 23797064.
3. Saez-Cirion A, Sinet M, Shin SY, Urrutia A, Versmisse P, Lacabaratz C, et al. Heterogeneity in HIV suppression by CD8 T cells from HIV controllers: association with Gag-specific CD8 T cell responses. J Immunol. 2009; 182(12):7828-37. Epub 2009/06/06. doi: 10.4049/jimmunol.0803928 PMID: 19494307.
4. Sáez-Cirión A, Lacabaratz C, Lambotte O, Versmisse P, Urrutia A, Boufassa F, et al. HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar CTL activation phenotype. Proc Natl Acad Sci U S A. 2007; 104(16):6776-81. PMID: 17428922
5. Betts MR, Nason MC, West SM, De Rosa SC, Migueles SA, Abraham J, et al. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood. 2006; 107(12):4781-9. Epub 2006/02/10. doi: 10.1182/blood-2005-12-4818 PMID: 16467198; PubMed Central PMCID: PMC1895811.
6. Migueles SA, Laborico AC, Shupert WL, Sabbaghian MS, Rabin R, Hallahan CW, et al. HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nat Immunol. 2002; 3(11):1061-8. Epub 2002/10/09. doi: 10.1038/ni845 PMID: 12368910.
7. Saez-Cirion A, Shin SY, Versmisse P, Barre-Sinoussi F, Pancino G. Ex vivo T cell-based HIV suppression assay to evaluate HIV-specific CD8+ T-cell responses. Nat Protoc. 2010; 5(6):1033-41. Epub 2010/06/12. doi: 10.1038/nprot.2010.73 PMID: 20539279.
8. Hersperger AR, Pereyra F, Nason M, Demers K, Sheth P, Shin LY, et al. Perforin expression directly ex vivo by HIV-specific CD8 T-cells is a correlate of HIV elite control. PLoS Pathog. 2010; 6(5):e1000917.Epub 2010/06/05. doi: 10.1371/journal.ppat.1000917 PMID: 20523897; PubMed Central PMCID: PMC2877741.
9. Migueles SA, Osborne CM, Royce C, Compton AA, Joshi RP, Weeks KA, et al. Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune control. Immunity. 2008; 29(6):1009-21. Epub 2008/12/09. doi: 10.1016/j.immuni.2008.10.010 PMID: 19062316; PubMed Central PMCID: PMC2622434.
10. Flores-Villanueva PO, Yunis EJ, Delgado JC, Vittinghoff E, Buchbinder S, Leung JY, et al. Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity. Proc Natl Acad Sci U S A. 2001; 98(9):5140-5. PMID: 11309482.
11. Migueles SA, Sabbaghian MS, Shupert WL, Bettinotti MP, Marincola FM, Martino L, et al. HLA B&z.ast;5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. Proc Natl Acad Sci U S A. 2000; 97(6):2709-14. PMID: 10694578.
12. Almeida JR, Price DA, Papagno L, Arkoub ZA, Sauce D, Bornstein E, et al. Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover. The Journal of experimental medicine. 2007; 204(10):2473-85. PMID: 17893201.
13. Lecuroux C, Saez-Cirion A, Girault I, Versmisse P, Boufassa F, Avettand-Fenoel V, et al. Both HLA-B&z.ast;57 and plasma HIV RNA levels contribute to the HIV-specific CD8+ T cell response in HIV controllers. J Virol. 2014; 88(1):176-87. doi: 10.1128/JVI.02098-13 PMID: 24131719; PubMed Central PMCID: PMCPMC3911721.
14. Emu B, Sinclair E, Hatano H, Ferre A, Shacklett B, Martin JN, et al. HLA class I-restricted T-cell responses may contribute to the control of human immunodeficiency virus infection, but such responses are not always necessary for long-term virus control. J Virol. 2008; 82(11):5398-407. PMID:18353945. doi: 10.1128/JVI.02176-07
15. Xu RH, Remakus S, Ma X, Roscoe F, Sigal LJ. Direct presentation is sufficient for an efficient anti-viral CD8+ T cell response. PLoS pathogens. 2010; 6(2):e1000768. Epub 2010/02/20. doi: 10.1371/journal. ppat.1000768 PMID: 20169189; PubMed Central PMCID: PMC2820535.
16. van Montfoort N, van der Aa E, Woltman AM. Understanding MHC class I presentation of viral antigens by human dendritic cells as a basis for rational design of therapeutic vaccines. Front Immunol. 2014; 5:182. Epub 2014/05/06. doi: 10.3389/fimmu.2014.00182 PMID: 24795724; PubMed Central PMCID: PMC4005948.
17. Smed-Sorensen A, Lore K, Vasudevan J, Louder MK, Andersson J, Mascola JR, et al. Differential susceptibility to human immunodeficiency virus type 1 infection of myeloid and plasmacytoid dendritic cells. Journal of virology. 2005; 79(14):8861-9. Epub 2005/07/05. doi: 10.1128/JVI.79.14.8861-8869.2005 PMID: 15994779; PubMed Central PMCID: PMC1168781.
18. Laguette N, Sobhian B, Casartelli N, Ringeard M, Chable-Bessia C, Segeral E, et al. SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature. 2011; 474 (7353):654-7. Epub 2011/05/27. doi: 10.1038/nature10117 PMID: 21613998; PubMed Central PMCID: PMC3595993.
19. Lahouassa H, Daddacha W, Hofmann H, Ayinde D, Logue EC, Dragin L, et al. SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates. Nat Immunol. 2012; 13(3):223-8. Epub 2012/02/14. doi: 10.1038/ni.2236 PMID: 22327569.
20. Beloglazova N, Flick R, Tchigvintsev A, Brown G, Popovic A, Nocek B, et al. Nuclease activity of the human SAMHD1 protein implicated in the Aicardi-Goutieres syndrome and HIV-1 restriction. J Biol Chem. 2013; 288(12):8101-10. Epub 2013/02/01. doi: 10.1074/jbc.M112.431148 PMID: 23364794; PubMed Central PMCID: PMC3605629.
21. Manel N, Hogstad B, Wang Y, Levy DE, Unutmaz D, Littman DR. A cryptic sensor for HIV-1 activates antiviral innate immunity in dendritic cells. Nature. 2010; 467(7312):214-7. Epub 2010/09/11. doi: 10. 1038/nature09337 PMID: 20829794; PubMed Central PMCID: PMC3051279.
22. Saez-Cirion A, Hamimi C, Bergamaschi A, David A, Versmisse P, Melard A, et al. Restriction of HIV-1 replication in macrophages and CD4+ T cells from HIV controllers. Blood. 2011; 118(4):955-64. doi: 10.1182/blood-2010-12-327106 PMID: 21642597; PubMed Central PMCID: PMCPMC3148172.
23. Chen H, Li C, Huang J, Cung T, Seiss K, Beamon J, et al. CD4+ T cells from elite controllers resist HIV-1 infection by selective upregulation of p21. J Clin Invest. 2011; 121(4):1549-60. Epub 2011/03/16. doi: 10.1172/JCI44539 PMID: 21403397; PubMed Central PMCID: PMC3069774.
24. Buzon MJ, Seiss K, Weiss R, Brass AL, Rosenberg ES, Pereyra F, et al. Inhibition of HIV-1 integration in ex vivo-infected CD4 T cells from elite controllers. J Virol. 2011; 85(18):9646-50. Epub 2011/07/08.doi: 10.1128/JVI.05327-11 PMID: 21734042; PubMed Central PMCID: PMC3165766.
25. Martin-Gayo E, Buzon MJ, Ouyang Z, Hickman T, Cronin J, Pimenova D, et al. Potent Cell-Intrinsic Immune Responses in Dendritic Cells Facilitate HIV-1-Specific T Cell Immunity in HIV-1 Elite Controllers. PLoS Pathog. 2015; 11(6):e1004930. doi: 10.1371/journal.ppat.1004930 PMID: 26067651; PubMed Central PMCID: PMCPMC4466270.
26. Manel N, Littman DR. Hiding in plain sight: how HIV evades innate immune responses. Cell. 2011; 147 (2):271-4. Epub 2011/10/18. doi: 10.1016/j.cell.2011.09.010 PMID: 22000008; PubMed Central PMCID: PMC3624893.
27. Harman AN, Lai J, Turville S, Samarajiwa S, Gray L, Marsden V, et al. HIV infection of dendritic cells subverts the IFN induction pathway via IRF-1 and inhibits type 1 IFN production. Blood. 2011; 118 (2):298-308. Epub 2011/03/18. doi: 10.1182/blood-2010-07-297721 PMID: 21411754; PubMed Central PMCID: PMC4123420.
28. Granelli-Piperno A, Golebiowska A, Trumpfheller C, Siegal FP, Steinman RM. HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation. Proceedings of the National Academy of Sciences of the United States of America. 2004; 101 (20):7669-74. Epub 2004/05/07. doi: 10.1073/pnas.0402431101 PMID: 15128934; PubMed Central PMCID: PMC419664.
29. Macatonia SE, Lau R, Patterson S, Pinching AJ, Knight SC. Dendritic cell infection, depletion and dysfunction in HIV-infected individuals. Immunology. 1990; 71(1):38-45. Epub 1990/09/01. PMID: 2145214; PubMed Central PMCID: PMCPMC1384218.
30. de Witte L, Bobardt M, Chatterji U, Degeest G, David G, Geijtenbeek TB, et al. Syndecan-3 is a dendritic cell-specific attachment receptor for HIV-1. Proceedings of the National Academy of Sciences of the United States of America. 2007; 104(49):19464-9. Epub 2007/11/28. doi: 10.1073/pnas.0703747104 PMID: 18040049; PubMed Central PMCID: PMC2148312.
31. Hong PW, Flummerfelt KB, de Parseval A, Gurney K, Elder JH, Lee B. Human immunodeficiency virus envelope (gp120) binding to DC-SIGN and primary dendritic cells is carbohydrate dependent but does not involve 2G12 or cyanovirin binding sites: implications for structural analyses of gp120-DC-SIGN binding. Journal of virology. 2002; 76(24):12855-65. Epub 2002/11/20. PMID: 12438611; PubMed Central PMCID: PMC136699.
32. Lai J, Bernhard OK, Turville SG, Harman AN, Wilkinson J, Cunningham AL. Oligomerization of the macrophage mannose receptor enhances gp120-mediated binding of HIV-1. The Journal of biological chemistry. 2009; 284(17):11027-38. Epub 2009/02/20. doi: 10.1074/jbc.M809698200 PMID: 19224860; PubMed Central PMCID: PMC2670108.
33. Moris A, Nobile C, Buseyne F, Porrot F, Abastado JP, Schwartz O. DC-SIGN promotes exogenous MHC-I-restricted HIV-1 antigen presentation. Blood. 2004; 103(7):2648-54. Epub 2003/10/25. doi: 10. 1182/blood-2003-07-2532 PMID: 14576049.
34. Singh SK, Stephani J, Schaefer M, Kalay H, Garcia-Vallejo JJ, den Haan J, et al. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation. Mol Immunol. 2009; 47(2-3):164-74. Epub 2009/10/13. doi: 10.1016/j.molimm.2009.09.026 PMID: 19818504.
35. Garcia-Vallejo JJ, Ambrosini M, Overbeek A, van Riel WE, Bloem K, Unger WW, et al. Multivalent glycopeptide dendrimers for the targeted delivery of antigens to dendritic cells. Mol Immunol. 2013; 53 (4):387-97. Epub 2012/10/30. doi: 10.1016/j.molimm.2012.09.012 PMID: 23103377.
36. Unger WW, van Beelen AJ, Bruijns SC, Joshi M, Fehres CM, van Bloois L, et al. Glycan-modified liposomes boost CD4+ and CD8+ T-cell responses by targeting DC-SIGN on dendritic cells. J Control Release. 2012; 160(1):88-95. Epub 2012/03/01. doi: 10.1016/j.jconrel.2012.02.007 PMID: 22366522.
37. Burgdorf S, Kautz A, Bohnert V, Knolle PA, Kurts C. Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8 T cell activation. Science. 2007; 316(5824):612-6. Epub 2007/04/28. doi: 10.1126/science.1137971 PMID: 17463291.
38. Geijtenbeek TB, Kwon DS, Torensma R, van Vliet SJ, van Duijnhoven GC, Middel J, et al. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell. 2000; 100 (5):587-97. Epub 2000/03/18. PMID: 10721995.
39. Nguyen DG, Hildreth JE. Involvement of macrophage mannose receptor in the binding and transmission of HIV by macrophages. Eur J Immunol. 2003; 33(2):483-93. Epub 2003/03/21. doi: 10.1002/ immu.200310024 PMID: 12645947.
40. Vingert B, Benati D, Lambotte O, de Truchis P, Slama L, Jeannin P, et al. HIV controllers maintain a population of highly efficient Th1 effector cells in contrast to patients treated in the long term. Journal of virology. 2012; 86(19):10661-74. Epub 2012/07/28. doi: 10.1128/JVI.00056-12 PMID: 22837194; PubMed Central PMCID: PMC3457309.
41. Vingert B, Perez-Patrigeon S, Jeannin P, Lambotte O, Boufassa F, Lemaitre F, et al. HIV controller CD4+ T cells respond to minimal amounts of Gag antigen due to high TCR avidity. PLoS pathogens. 2010; 6(2):e1000780. Epub 2010/03/03. doi: 10.1371/journal.ppat.1000780 PMID: 20195518; PubMed Central PMCID: PMC2829066.
42. Palmer P, Tovey MG, Raschilas F, Brassart L, Meritet JF, Porcher R, et al. Type I interferon subtypes produced by human peripheral mononuclear cells from one normal donor stimulated by viral and nonviral inducing factors. Eur Cytokine Netw. 2007; 18(2):108-14. Epub 2007/06/28. doi: 10.1684/ecn. 2007.0093 PMID: 17594944.